Are you attending the ISSCR 2013 Annual Meeting this week in Boston? Want to get your voice heard about what you think of the meeting or specific talks or the most interesting thing you heard at the bar? You have an invitation to guest blog here on ipscell.com. Send me your ideas or draft posts, […]
Call for guest ISSCR 2013 bloggers: audience of thousands awaits you Read More »
I recently did a poll asking people if they are or are not going to ISSCR and in either case, why. The results (at right) are pretty interesting. The #1 answer was that respondents were not going and the reason was that attending would be too expensive. Two other reasons given for not attending (tied
ISSCR 2013 poll results: encouraging but travel awards needed Read More »
The ISSCR Annual Meeting will be held In Boston, MA in June. In advance of the meeting I was looking through the Preliminary Program that showed up in my mail box and then I checked out the confirmed speakers page on the web. What a cool lineup of speakers, I thought, but something seemed different….at
ISSCR Breaks Tradition with 2013 Annual Meeting Read More »
I have an ongoing poll on people’s impressions of the big annual stem cell meeting, ISSCR 2012. I myself have been wishing I was in Japan for that meeting so I remain surprised at the trending of the poll toward the negative. By far the most common response has been a surprisingly ho-hum “so-so” evaluation
Wish list from 2012 attendees for ISSCR 2013: some crankiness Read More »
What is ISSCR doing about unproven stem cell clinics? One of the greatest and most infuriating ironies of the stem cell-based regenerative medicine universe is that while the FDA strictly regulates the progress of therapy development by Advanced Cell Technology (ACT) and Geron and other legitimate companies, at the same time mysteriously the FDA essentially
ISSCR KO’d in round one versus unproven clinics: where’s the FDA? Read More »
Remember former Trump’s FDA Commissioner Scott Gottlieb? Gottlieb’s back in the news in an interesting way related to the upcoming second Trump administration. I just wrote about what to expect from new FDA Commissioner nominee Marty Makary. In that piece, I noted that Scott Gottlieb first came to lead the FDA after a record of
Weekly reads: Scott Gottlieb v. RFK Jr., DNA typewriters, Arnold Caplan Read More »
After a bit of a hiatus in 2024, our list of regenerative medicine and stem cell meetings returns for 2025. I’m noticing a lot of great stem cell meetings already scheduled for 2025. With the pandemic being less of an ever-present thing, most meetings are now only in-person these days. In a way, the hybrid
2025 regenerative medicine and stem cell meetings list Read More »
There should be more stem cell awards. Why not recognize more scientists and advocates? I used to do a Stem Cell Person of the Year Award. I have thought about bringing it back. What do you think? Scroll through some past posts on the Stem Cell Person of the Year Award. ISSCR gives out stem
Weekly reads: Rusty Gage & stem cell awards, ASCL1, stem cells for a vulture Read More »
Who decides what to name something new in science like “human embryo models”? Also, not to get too philosophical right off the bat, but what is the point of a name? It’s about a shared understanding of what we’re talking about. But, very often, both out in the world and in the various fields of
Beyond naming: embryo models and the importance of public dialogue Read More »
The International Society for Cell & Gene Therapy or ISCT is a great organization in our field. They have launched a new guide to help healthcare providers navigate this complex area. Click on the image below to check it out. This new resource is important because healthcare providers, researchers, and the public need authoritative information.
ISCT launches new resource on unproven cell & gene therapies Read More »